HERON THERAPEUTICS INC

Ticker: HRTX CUSIP: 427746102 Class: COM

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 1,308,861 Value ($000) $1,649 Avg Close $1.59 Range $1.18 - $2.30
Q2 2025
Shares 2,894,072 Value ($000) $5,991 Avg Close $2.04 Range $1.65 - $2.61
Q1 2025
Shares 1,254,696 Value ($000) $2,760 Avg Close $1.94 Range $1.46 - $2.68
Q4 2024
Shares 1,017,539 Value ($000) $1,557 Avg Close $1.62 Range $1.04 - $2.15
Q3 2024
Shares 1,715,545 Value ($000) $3,414 Avg Close $2.39 Range $1.71 - $3.73
Q2 2024
Shares 1,761,051 Value ($000) $6,164 Avg Close $3.07 Range $2.27 - $3.93
Q1 2024
Shares 494,354 Value ($000) $1,369 Avg Close $2.51 Range $1.66 - $3.22
Q2 2019
Shares 68,904 Value ($000) $1,281 Avg Close $19.98 Range $16.20 - $26.59
Q1 2019
Shares 203 Value ($000) $5 Avg Close $26.18 Range $22.87 - $28.70
Q4 2018
Shares 21,046 Value ($000) $546 Avg Close $27.49 Range $21.25 - $32.45
Q3 2018
Shares 29,910 Value ($000) $947 Avg Close $37.25 Range $29.30 - $41.55
Q1 2018
Shares 12,100 Value ($000) $334 Avg Close $22.68 Range $17.85 - $32.70